Variables | Frequency (%) | Death (%) | Survived (%) | P-value |
---|---|---|---|---|
Drug side effect(n = 414) | ||||
Yes | 77(18.60) | 6(26.10) | 71(18.20) | 0.34 |
ART eligibility criteria | ||||
Immunologic | 96(23.19) | 4(17.40) | 92(23.50) | 0.10 |
WHO stage | 38(9.18) | 1(4.30) | 37(9.50) | |
Both | 222(53.62) | 18(78.30) | 204(52.20) | |
Without criteria | 58(14.01) | - | 58(14.83) | |
Date b/n ART eligibility—initiation | ||||
< 7 days | 211(50.97) | 11(47.80) | 200(51.20) | 0.90 |
≥ 7 days | 203(49.03) | 12(52.20) | 191(48.80) | |
Regimen change | ||||
Yes | 270(65.22) | 9(39.10) | 261(66.75) | 0.006 |
Change was ( N = 270) | ||||
Within first line | 245(90.74) | 7(77.77) | 238(91.20) | 0.12 |
To second line | 25(9.26) | 2(22.23) | 23(8.80) | |
Reason for change | ||||
Drug side effect | 76(28.15) | 4(44.44) | 72(27.60) | 0.81 |
OI | 4(1.48) | 1(11.11) | 3(1.15) | |
Treatment failure | 20(7.41) | 2(22.22) | 18(6.90) | |
Drug stock out | 34(12.59) | - | 34(13.00) | |
New drug | 113(41.85) | 2(22.22) | 111(42.50) | |
Others | 23(8.52) | - | 23(8.80) | |
Adherence | ||||
Good | 385(93.00) | 20(87.00) | 365(93.40) | 0.0001 |
Fair | 1(0.24) | 1(4.3%) | - | |
Poor | 28(6.76) | 2(8.70) | 26(6.60) |